IL153916A0 - Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride obtained from said solvates - Google Patents
Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride obtained from said solvatesInfo
- Publication number
- IL153916A0 IL153916A0 IL15391602A IL15391602A IL153916A0 IL 153916 A0 IL153916 A0 IL 153916A0 IL 15391602 A IL15391602 A IL 15391602A IL 15391602 A IL15391602 A IL 15391602A IL 153916 A0 IL153916 A0 IL 153916A0
- Authority
- IL
- Israel
- Prior art keywords
- solvates
- lercanidipine hydrochloride
- crystalline forms
- new crystalline
- lercanidipine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001MI001727A ITMI20011727A1 (it) | 2001-08-06 | 2001-08-06 | Solvati della lercanidipina cloridrato e nuove forme cristalline della lercanidipina cloridrato ottenute da essi |
| PCT/EP2002/008700 WO2003014085A1 (en) | 2001-08-06 | 2002-08-05 | Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL153916A0 true IL153916A0 (en) | 2003-07-31 |
Family
ID=11448246
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15391602A IL153916A0 (en) | 2001-08-06 | 2002-08-05 | Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride obtained from said solvates |
| IL153916A IL153916A (en) | 2001-08-06 | 2003-01-13 | Larknidipine Hydrochloride Solutions and Crystalline Forms of Larknidipine Hydrochloride |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL153916A IL153916A (en) | 2001-08-06 | 2003-01-13 | Larknidipine Hydrochloride Solutions and Crystalline Forms of Larknidipine Hydrochloride |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1423367B1 (xx) |
| JP (1) | JP2005502648A (xx) |
| KR (1) | KR100912664B1 (xx) |
| CN (1) | CN100494175C (xx) |
| AR (1) | AR037230A1 (xx) |
| AT (1) | ATE294162T1 (xx) |
| AU (1) | AU2002331390B2 (xx) |
| BR (1) | BR0211738A (xx) |
| DE (1) | DE60203919D1 (xx) |
| EA (1) | EA200400279A1 (xx) |
| ES (1) | ES2209684T1 (xx) |
| HR (1) | HRP20040157A2 (xx) |
| HU (1) | HUP0401161A3 (xx) |
| IL (2) | IL153916A0 (xx) |
| IT (1) | ITMI20011727A1 (xx) |
| MX (1) | MXPA04001073A (xx) |
| NO (1) | NO20040479L (xx) |
| PE (1) | PE20030350A1 (xx) |
| PL (1) | PL369449A1 (xx) |
| UY (1) | UY27409A1 (xx) |
| WO (1) | WO2003014085A1 (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100651212B1 (ko) | 2004-10-27 | 2006-12-01 | 제일약품주식회사 | 무정형 레르카니디핀의 제조방법 |
| AR052918A1 (es) | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
| WO2007031865A2 (en) * | 2005-09-16 | 2007-03-22 | Glenmark Pharmaceuticals Limited | Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof |
| EP2121575A2 (en) * | 2007-03-05 | 2009-11-25 | Actavis Group PTC EHF | Lercanidipine hydrochloride polymorphs and an improved process for preparation of 1,1,n-trimethyl-n-(3,3-diphenylpropyl)-2-aminoethyl acetoacetate |
| WO2008136393A1 (ja) * | 2007-04-27 | 2008-11-13 | Ajinomoto Co., Inc. | ラクタム化合物の結晶形およびその製造方法 |
| WO2011161223A2 (en) | 2010-06-23 | 2011-12-29 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts |
| SI2654729T1 (sl) | 2010-12-24 | 2016-08-31 | Krka, D.D., Novo Mesto | Homogene farmacevtske oralne dozirne oblike, ki obsegajo lerkanidipin in enalapril ali njune farmacevtsko sprejemljive soli skupaj z organsko kislino |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
| US5912351A (en) | 1995-05-12 | 1999-06-15 | Recordati, S.A. Chemical And Pharmaceutical Company | Anhydrous 1,4-Dihydropyridines and salts thereof |
-
2001
- 2001-08-06 IT IT2001MI001727A patent/ITMI20011727A1/it unknown
-
2002
- 2002-08-02 AR ARP020102957A patent/AR037230A1/es not_active Application Discontinuation
- 2002-08-05 IL IL15391602A patent/IL153916A0/xx unknown
- 2002-08-05 DE DE60203919T patent/DE60203919D1/de not_active Expired - Lifetime
- 2002-08-05 MX MXPA04001073A patent/MXPA04001073A/es not_active Application Discontinuation
- 2002-08-05 EA EA200400279A patent/EA200400279A1/ru unknown
- 2002-08-05 JP JP2003519035A patent/JP2005502648A/ja active Pending
- 2002-08-05 WO PCT/EP2002/008700 patent/WO2003014085A1/en active IP Right Grant
- 2002-08-05 BR BR0211738-0A patent/BR0211738A/pt not_active IP Right Cessation
- 2002-08-05 PL PL02369449A patent/PL369449A1/xx unknown
- 2002-08-05 CN CNB028155114A patent/CN100494175C/zh not_active Expired - Fee Related
- 2002-08-05 HU HU0401161A patent/HUP0401161A3/hu unknown
- 2002-08-05 AU AU2002331390A patent/AU2002331390B2/en not_active Ceased
- 2002-08-05 EP EP02767318A patent/EP1423367B1/en not_active Expired - Lifetime
- 2002-08-05 KR KR1020047001791A patent/KR100912664B1/ko not_active IP Right Cessation
- 2002-08-05 AT AT02767318T patent/ATE294162T1/de not_active IP Right Cessation
- 2002-08-05 ES ES02767318T patent/ES2209684T1/es active Pending
- 2002-08-06 PE PE2002000716A patent/PE20030350A1/es not_active Application Discontinuation
- 2002-08-06 UY UY27409A patent/UY27409A1/es not_active Application Discontinuation
-
2003
- 2003-01-13 IL IL153916A patent/IL153916A/en unknown
-
2004
- 2004-02-03 NO NO20040479A patent/NO20040479L/no not_active Application Discontinuation
- 2004-02-18 HR HR20040157A patent/HRP20040157A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI20011727A1 (it) | 2003-02-06 |
| MXPA04001073A (es) | 2005-02-17 |
| AR037230A1 (es) | 2004-11-03 |
| PL369449A1 (en) | 2005-04-18 |
| EP1423367A1 (en) | 2004-06-02 |
| KR20040030932A (ko) | 2004-04-09 |
| UY27409A1 (es) | 2003-03-31 |
| KR100912664B1 (ko) | 2009-08-17 |
| JP2005502648A (ja) | 2005-01-27 |
| ITMI20011727A0 (it) | 2001-08-06 |
| EA200400279A1 (ru) | 2004-06-24 |
| IL153916A (en) | 2008-07-08 |
| NO20040479L (no) | 2004-02-03 |
| AU2002331390B2 (en) | 2008-06-05 |
| CN100494175C (zh) | 2009-06-03 |
| HUP0401161A3 (en) | 2009-04-28 |
| BR0211738A (pt) | 2004-09-28 |
| ES2209684T1 (es) | 2004-07-01 |
| ATE294162T1 (de) | 2005-05-15 |
| HRP20040157A2 (en) | 2004-08-31 |
| DE60203919D1 (de) | 2005-06-02 |
| EP1423367B1 (en) | 2005-04-27 |
| PE20030350A1 (es) | 2003-06-06 |
| WO2003014085A1 (en) | 2003-02-20 |
| CN1538958A (zh) | 2004-10-20 |
| HUP0401161A2 (hu) | 2004-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL161372A0 (en) | Crystalline solvates of paclitaxel | |
| HK1086263A1 (en) | Crystal form of lercanidipine hydrochloride for use as an antihypertensive agent | |
| HRP20040077A2 (en) | Crystalline forms vi and vii of atorvastatin-calcium | |
| IL160721A0 (en) | Crystalline forms of valacyclovir hydrochloride | |
| TW582568U (en) | Fixing apparatus of back-plate | |
| AU1234002A (en) | Crystalline forms of venlafaxine hydrochloride | |
| EP1463820A4 (en) | METHOD FOR SCREENING CONNECTIONS | |
| IL153916A0 (en) | Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride obtained from said solvates | |
| IL159266A0 (en) | Crystalline forms of fexofenadine and processes for the preparation thereof | |
| AU2002303552A8 (en) | Methods and compositions for prevention of angioproliferation | |
| IL161178A0 (en) | MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES | |
| IL161521A0 (en) | N-formyl derivatives of paroxetine | |
| IL157243A0 (en) | Preparation of n-methylparoxetine and related intermediate compounds | |
| EP1435953A4 (en) | ANTI-VESICANS COMPOUNDS AND METHOD FOR THEIR PREPARATION AND USE | |
| PL351128A1 (en) | Method of obtaining phenoglycine and derivatives thereof | |
| EP1469308A4 (en) | METHOD OF SCREENING A MEDICAMENT | |
| TW545219U (en) | Improved structure of head-hanging-type earplug | |
| GB0120884D0 (en) | Materials and methods for prevention of obesity | |
| AU2002238356A1 (en) | New use of phencynonate hydrochloride | |
| AU2002237189A1 (en) | New use of phencynonate hydrochloride | |
| GB0125119D0 (en) | Process of preparing paroxetine and intermediates for use therein | |
| ZA200601326B (en) | Crystalline forms of valacyclovir hydrochloride | |
| TW490029U (en) | Structure improvement of hand-held camcorder | |
| PL341366A1 (en) | Method of obtaining amlodipin benzenesulphonate | |
| TW484488U (en) | Improved structure of quick-withdrawn wrench |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed |